New and Recurrent Cancers After MRNA Vaccines, Studies Suggest Immune Changes
Since receiving Moderna COVID-19 vaccines, Bonnie Eisenberg experienced relapse of her breast cancer 7 years after being in remission.
The 73-year-old was diagnosed with stage 2 breast cancer in 2012. After successful treatment, she had been in remission since 2014.
Ever since then, her doctor has measured tumor marker levels in her body to monitor for relapse.
Tumor markers are usually proteins that indicate possible tumor or cancer growth. High levels of tumor markers may indicate cancer but it is not definitive.
There are many markers that can be tested, but the one that her doctor particularly focused on was the carcinoembryonic antigen (CEA), a tumor marker common to cancers of the breast, colon and rectum, prostate, ovary, lung, thyroid, and liver….